Gene mapping of childhood blood cancers could unlock personalized treatments
NCT ID NCT04968834
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This research study collects and analyzes blood and bone marrow samples from children and young adults with leukemia, myelodysplastic syndrome, or myeloproliferative syndrome. By reading the genetic instructions in these cancer cells, scientists hope to understand why the disease develops and why some patients respond differently to treatments. The samples are stored for future research, and the genetic results are shared with each patient's doctor.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- genomic profiling using a CLIA-certified assay
- What this could lead to
- If successful, this research could reveal genetic clues that improve how blood cancers in young people are diagnosed and treated.
- What could go wrong
- This is an observational, sample-collection study, not a treatment trial. It may not directly lead to new therapies, and results depend on sample quality and availability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Albany Medical Center
RECRUITINGAlbany, New York, 12208, United States
Contact Email: •••••@•••••
-
Boston Children's Hospital
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02115, United States
-
Connecticut Children's Medical Center
RECRUITINGHartford, Connecticut, 06106, United States
Contact Email: •••••@•••••
-
Dana Farber Cancer Institute
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02215, United States
-
Dartmouth-Hitchcock
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact Email: •••••@•••••
-
Lifespan Cancer Institute
RECRUITINGProvidence, Rhode Island, 02903, United States
Contact Email: •••••@•••••
-
Maine Medical Center
RECRUITINGPortland, Maine, 04102, United States
Contact Email: •••••@•••••
-
University of Vermont Medical Center
RECRUITINGBurlington, Vermont, 05401, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A pill that mimics the body's oxygen sensor may free MDS patients from frequent blood transfusions
- New PET tracer could sharpen diagnosis of blood cancers
- 10,000 DNA samples could reveal hidden genetic triggers for leukemia and lymphoma
- Could bone marrow from deceased donors cure blood cancers?
- Drug combo aims to break anemia cycle in MDS patients
- New dashboard aims to make leukemia trials more inclusive